Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3903 ARTÍCULOS , VIENDO DEL 1486 AL 1500

Rationale and design of REWARD (revving-up exercise for sustained weight loss by altering neurological reward and drive): a randomized trial in obese endometrial cancer survivors

Nock NL, Dimitropoulos A, Rao SM, Flask CA, Schluchter M, Zanotti KM, Rose PG, Kirwan JP, Alberts J.

Contemp Clin Trials. 2014 Nov;39(2):236-45. doi: 10.1016/j.cct.2014.08.008. Epub 2014 Aug 17.

Pharmacological Treatments Inhibiting Levodopa-Induced Dyskinesias in MPTP-Lesioned Monkeys: Brain Glutamate Biochemical Correlates

Morin N, Di Paolo T.

Front Neurol. 2014 Aug 5;5:144. doi: 10.3389/fneur.2014.00144. eCollection 2014.

Essential tremor versus Parkinson disease: Make the right diagnosis

Boyar K.

Nurse Pract. 2014 Sep 18;39(9):13-6. doi: 10.1097/01.NPR.0000452984.51256.1a.

Study protocol: the JEU cohort study--transversal multiaxial evaluation and 5-year follow-up of a cohort of French gamblers

Challet-Bouju G, Hardouin JB, Vénisse JL, Romo L, Valleur M, Magalon D, Fatséas M, Chéreau-Boudet I, Gorsane MA; JEU Group; Grall-Bronnec M.

BMC Psychiatry. 2014 Aug 20;14:226. doi: 10.1186/s12888-014-0226-7.

The role of advanced glycation end products in various types of neurodegenerative disease: a therapeutic approach

Salahuddin P, Rabbani G, Khan RH.

Cell Mol Biol Lett. 2014 Sep;19(3):407-37. doi: 10.2478/s11658-014-0205-5. Epub 2014 Aug 20.

Lardy brains make Parkinson's disease mice worse

Cookson MR.

J Neurochem. 2014 Dec;131(6):697-8. doi: 10.1111/jnc.12843. Epub 2014 Aug 20.

Plant secondary metabolites- potent inhibitors of monoamine oxidase isoforms

Mathew B, Suresh J, Mathew GE, Parasuraman R, Abdulla N.

Cent Nerv Syst Agents Med Chem. 2014;14(1):28-33. doi: 10.2174/1871524914666140826111930.

Therapeutics with SPION-labeled stem cells for the main diseases related to brain aging: a systematic review

Alvarim LT, Nucci LP, Mamani JB, Marti LC, Aguiar MF, Silva HR, Silva GS, Nucci-da-Silva MP, DelBel EA, Gamarra LF.

Int J Nanomedicine. 2014 Aug 11;9:3749-70. doi: 10.2147/IJN.S65616. eCollection 2014.

Functional outcomes associated with expiratory muscle strength training: narrative review

Laciuga H, Rosenbek JC, Davenport PW, Sapienza CM.

J Rehabil Res Dev. 2014;51(4):535-46. doi: 10.1682/JRRD.2013.03.0076.

Rotigotine transdermal system: developing continuous dopaminergic delivery to treat Parkinson's disease and restless legs syndrome

Benitez A, Edens H, Fishman J, Moran K, Asgharnejad M.

Ann N Y Acad Sci. 2014 Nov;1329:45-66. doi: 10.1111/nyas.12508. Epub 2014 Aug 21.

Emerging drugs for levodopa-induced dyskinesia

Al Dakheel A, Beaulieu-Boire I, Fox SH.

Expert Opin Emerg Drugs. 2014 Sep;19(3):415-29. doi: 10.1517/14728214.2014.955014. Epub 2014 Aug 22.

Group III metabotropic glutamate receptors: pharmacology, physiology and therapeutic potential

Mercier MS, Lodge D.

Neurochem Res. 2014 Oct;39(10):1876-94. doi: 10.1007/s11064-014-1415-y. Epub 2014 Aug 22.

IPX066 , a mixed immediate/sustained-release levodopa preparation for Parkinson's disease

Ondo W.

Expert Opin Pharmacother. 2014 Oct;15(14):2081-5. doi: 10.1517/14656566.2014.950224. Epub 2014 Aug 22.

Mild cognitive impairment and Parkinson's disease--something to remember

Barker RA, Williams-Gray CH.

J Parkinsons Dis. 2014;4(4):651-6. doi: 10.3233/JPD-140427.

The degeneration and replacement of dopamine cells in Parkinson's disease: the role of aging

Rodriguez M, Morales I, Rodriguez-Sabate C, Sanchez A, Castro R, Brito JM, Sabate M.

Front Neuroanat. 2014 Aug 7;8:80. doi: 10.3389/fnana.2014.00080. eCollection 2014.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias